Globus Medical, Inc.
GMED
$58.17
-$0.08-0.14%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 75.46M | 26.51M | 51.84M | 31.76M | -7.12M |
| Total Depreciation and Amortization | 66.14M | 68.23M | 66.95M | 63.59M | 55.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.10M | 88.34M | 50.02M | 75.87M | 46.82M |
| Change in Net Operating Assets | 9.60M | 27.27M | 34.86M | -116.96M | -42.72M |
| Cash from Operations | 177.30M | 210.34M | 203.65M | 54.26M | 52.39M |
| Capital Expenditure | -36.10M | -17.11M | -41.95M | -27.80M | -28.57M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | -100.00K | -4.89M | -12.65M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 167.49M | -87.01M | 27.09M | 22.31M | -5.37M |
| Cash from Investing | 131.39M | -104.12M | -14.97M | -10.38M | -46.58M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -449.99M | -- | -- | -- | -- |
| Issuance of Common Stock | 11.22M | 69.28M | 23.51M | 14.24M | 3.41M |
| Repurchase of Common Stock | -192.74M | -934.00K | -840.00K | -2.08M | -88.66M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.89M | -8.62M | -3.08M | -3.45M | -30.48M |
| Cash from Financing | -635.40M | 59.73M | 19.58M | 8.71M | -115.72M |
| Foreign Exchange rate Adjustments | 3.54M | -4.28M | 4.07M | 3.77M | -3.31M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -323.17M | 161.67M | 212.34M | 56.36M | -113.23M |